# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division: Laboratory Criteria

Extent: E+W+S+N.I.

At least one of the following four:
Isolation/cultivation of Escherichia coli that produces Shiga toxin/verocytotoxin or harbours stx1/vtx1 or stx2/vtx2 gene(s)
Isolation of non-sorbitol-fermenting (NSF) Escherichia coli O157 (without testing for the toxin or toxin-producing genes)
Direct detection of stx1/vtx1 or stx2/vtx2 gene(s) nucleic acid
Direct detection of free Shiga toxin/verocytotoxin in faeces
Only for HUS the following can be used as a laboratory criterion to confirm STEC/VTEC:
Escherichia coli serogroup-specific (LPS) antibody response

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/3/division/3.40/division/2 (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.40/division-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.